CLINDAMYCINE KABI 600 mg/4 ml, solution for injection 5 ampoules of 4 ml
Active ingredients: Clindamycin, Clindamycin phosphate
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only, hospital use
Solution for injection5 ampoules of 4 mlintramusculaire;intraveineuse
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- CLINDAMYCINE KABI 600 mg/4 ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 5 ampoule(s) en verre de 4 ml
- Marketing authorisation holder
- FRESENIUS KABI FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 May 2009
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63185288CIP75729438CIP133400957294380Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PHOSPHATE DE CLINDAMYCINEsolution | — | SA |
| CLINDAMYCINE BASEsolution | 600 mg · 4 ml de solution injectable | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.